American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Berger
    Berger
  7. Baselga
    Baselga
  8. Reis-Filho
    Reis-Filho
  9. Cordon-Cardo
    Cordon-Cardo
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)
  7. Human Oncology and Pathogenesis Program (677)
  8. Surgery (639)
  9. Breast Medicine Service (605)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (570)
Search Within
Formats
  1. Meeting Abstract (1996)
  2. Journal Article (1966)
  3. Editorial (41)
  4. Review (22)
  5. Conference Paper (14)
  6. Correspondence (4)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2074)
  2. Solid Tumor Oncology Division (1737)
  3. GSK Faculty (1623)
  4. Sloan Kettering Institute Faculty (794)
  5. Sloan Kettering Institute Postdocs (766)
  6. Department of Pathology and Laboratory Medicine (715)

More Groups

People
  1. David Solit (174)
  2. Marc Ladanyi (157)
  3. Neal Rosen (141)
  4. Clifford Hudis (140)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (6)
  2. 2024 (55)
  3. 2023 (63)
  4. 2022 (261)
  5. 2021 (233)
  6. 2020 (271)

More Years

Publications
  1. Cancer Research (2685)
  2. Clinical Cancer Research (1363)

Results (4048)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes
    Editorial

    Bolton, K. L.; Chen, D.; de la Fuente, R. C.; Fu, Z.; Murali, R.; KoĢˆbel, M.; Tazi, Y.; Cunningham, J. M.; Chan, I. C. C.; Wiley, B. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinico-genomic characterization of ATM and HRD in pancreas cancer: Application for practice
    Journal Article

    Park, W.; O'Connor, C. A.; Bandlamudi, C.; Forman, D.; Chou, J. F.; Umeda, S.; Reyngold, M.; Varghese, A. M.; Keane, F.; Balogun, F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • XL-ing at induction of apoptosis in kidney cancer through inhibition of BCL-X(L)
    Editorial

    Wang, N.; Hakimi, A. A.; Chen, Y.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors
    Journal Article

    Solomon, J. P.; Yang, S. R.; Choudhury, N. J.; Ptashkin, R. N.; Eslamdoost, N.; Falcon, C. J.; Martin, A.; Plodkowski, A.; Wilhelm, C.; Shen, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Rb tumor suppressor in small cell lung cancer: Combined genomic and IHC analysis with a description of a distinct Rb-proficient subset
    Editorial

    Febres-Aldana, C. A.; Chang, J. C.; Ptashkin, R.; Wang, Y.; Gedvilaite, E.; Baine, M. K.; Travis, W. D.; Ventura, K.; Bodd, F.; Yu, H. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic landscapes and hallmarks of mutant RAS in human cancers
    Journal Article

    Scharpf, R. B.; Balan, A.; Ricciuti, B.; Fiksel, J.; Cherry, C.; Wang, C.; Lenoue-Newton, M. L.; Rizvi, H. A.; White, J. R.; Baras, A. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase IB study of GITR agonist antibody TRX518 singly and in combination with gemcitabine, pembrolizumab, or nivolumab in patients with advanced solid tumors
    Journal Article

    Davar, D.; Zappasodi, R.; Wang, H.; Naik, G. S.; Sato, T.; Bauer, T.; Bajor, D.; Rixe, O.; Newman, W.; Qi, J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma
    Journal Article

    Manning-Geist, B.; Gordhandas, S.; Liu, Y. L.; Zhou, Q.; Iasonos, A.; Da Cruz Paula, A.; Mandelker, D.; Long Roche, K.; Zivanovic, O.; Maio, A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: